Enterococcus faecium biofilm formation: identification of major autolysin AtlAEfm, associated Acm surface

Fernanda L Paganelli1, Rob J L Willems, Pamela Jansen

  • 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Mbio
|April 18, 2013
PubMed

Insights

We identified AtlAEfm as the major autolysin in Enterococcus faecium, crucial for biofilm stability and virulence. Disrupting AtlAEfm reduces biofilm formation and pathogen attachment, offering a new therapeutic target for nosocomial infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Enterococcus faecium is a multidrug-resistant pathogen causing nosocomial infections, often via biofilms.
  • Biofilm pathogenesis is key to developing new treatment strategies.
  • Bacterial autolysins are vital for extracellular DNA (eDNA) release, contributing to biofilm stability.

Purpose of the Study:

  • To identify and functionally characterize the major autolysin in Enterococcus faecium.
  • To investigate the role of this autolysin in biofilm formation and virulence.
  • To explore AtlAEfm as a potential therapeutic target.

Main Methods:

  • Bioinformatic genome screening to identify putative autolysin genes.
  • Insertional gene disruption of candidate autolysin genes in E. faecium E1162.
  • Phenotypic analysis of mutant strains, including biofilm formation, cell attachment, and cell wall hydrolysis.

Main Results:

  • Identification and renaming of the major autolysin as AtlAEfm (locus tag EfmE1162_2692).
  • AtlAEfm disruption led to resistance to lysis, reduced eDNA release, deficient cell attachment, decreased biofilm, and cell chaining.
  • AtlAEfm influences cell surface exposure of the virulence factor Acm, affecting collagen binding.

Conclusions:

  • AtlAEfm is the primary autolysin in E. faecium, essential for biofilm stability and virulence.
  • AtlAEfm plays a novel role in the localization of the virulence factor Acm.
  • Targeting AtlAEfm presents a promising strategy for combating E. faecium biofilm-mediated infections.